LENZ Therapeutics (LENZ)

• Market cap: $278M
• 1 day: -1.11%
• 5 days: -5.53%
• 1 month: -5.03%
• 3 months: -45.52%
• 6 months: -68.21%
• Year to date: -44.5%
• 1 year: -69.25%
• 5 years: -93.14%
• 10 years: -93.14%
• Sector: Healthcare
• Industry: Biotechnology

About: LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Employees: 152